Cue Biopharma (CUE) Stock Price, Quote, News & History

Comments

Cue Biopharma Inc (CUE) Stock Price, Quote, News & History

CUENASDAQ

Trade with Public

$0.2260

-0.0134-5.60%

At close: Mar 27, 5:00 PM EST

$0.2188

-0.0206-8.60%

Pre-Market: 5:39 AM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$0.23

Volume / Avg.

7.53K / 1.61M

Day Range

- - -

52 Wk Range

0.21 - 1.05

Market Cap

$21.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

2.34%

Days to Cover

2.14

Recent Cue Biopharma Inc News

What's Going On With Cue Biopharma Shares Tuesday?

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

Dylan Berman

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Avi Kapoor

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Ragothaman Srinivasan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.69M

Investing Cash Flow (TTM)

75.00K

Financing Cash Flow (TTM)

26.29M

Free Cash Flow (TTM)

-21.86M

Capital Expenditure (TTM)

-177.00K

Net Change in Cash (TTM)

4.68M

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$711.40K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.79

PB Ratio (TTM)

0.84

Earnings Yield % (TTM)

-123.02%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.27

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$4.50M

Total Cash

$27.14M

Debt to Equity

0.16

Issuance of Debt (TTM)

-$4.50M

Repayment of Debt (TTM)

-$4.50M

Key Statistics

Open

-

Close

$0.23

Volume / Avg.

7.53K / 1.61M

Day Range

- - -

52 Wk Range

0.21 - 1.05

Market Cap

$21.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

2.34%

Days to Cover

2.14

About

Sector

Health Care

Industry

Biotechnology

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cue Biopharma (CUE) stock?

A

You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cue Biopharma (CUE) competitors?

A

Other companies in Cue Biopharma’s space includes: Serina Therapeutics Inc (AMEX:SER), Outlook Therapeutics Inc (NASDAQ:OTLK), Skye Bioscience Inc (NASDAQ:SKYE), Curis Inc (NASDAQ:CRIS) and Nanoviricides Inc (AMEX:NNVC).

Q

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

A

Cue Biopharma has a consensus price target of $5.13.

Q

What is the current price for Cue Biopharma (CUE)?

A

The stock price for Cue Biopharma (NASDAQ: CUE) is $0.2188 last updated March 31, 2026 at 5:09 AM EDT.

Q

Does Cue Biopharma (CUE) pay a dividend?

A

There are no upcoming dividends for Cue Biopharma.

Q

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

A

Cue Biopharma does not have any upcoming earnings scheduled.

Q

Is Cue Biopharma (CUE) going to split?

A

There is no upcoming split for Cue Biopharma.

Q

What sector and industry does Cue Biopharma (CUE) operate in?

A

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Serina Therapeutics Inc

AMEX:SER

$1.90

5.01%

Outlook Therapeutics Inc

NNVC

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.56

1.79%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.56

2.48%

Tevogen Bio Holdings Inc

NASDAQ:TVGN

$4.97

13.68%

Key Statistics

Open

-

Close

$0.23

Volume / Avg.

7.53K / 1.61M

Day Range

- - -

52 Wk Range

0.21 - 1.05

Market Cap

$21.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

2.34%

Days to Cover

2.14

Recent Cue Biopharma Inc News

What's Going On With Cue Biopharma Shares Tuesday?

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

Dylan Berman

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Avi Kapoor

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Ragothaman Srinivasan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-21.69M

Investing Cash Flow (TTM)

75.00K

Financing Cash Flow (TTM)

26.29M

Free Cash Flow (TTM)

-21.86M

Capital Expenditure (TTM)

-177.00K

Net Change in Cash (TTM)

4.68M

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$711.40K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.79

PB Ratio (TTM)

0.84

Earnings Yield % (TTM)

-123.02%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.27

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$4.50M

Total Cash

$27.14M

Debt to Equity

0.16

Issuance of Debt (TTM)

-$4.50M

Repayment of Debt (TTM)

-$4.50M

Key Statistics

Open

-

Close

$0.23

Volume / Avg.

7.53K / 1.61M

Day Range

- - -

52 Wk Range

0.21 - 1.05

Market Cap

$21.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

2.34%

Days to Cover

2.14

About

Sector

Health Care

Industry

Biotechnology

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry